In this episode, Sean Brodrick and John Eade unpack today’s market drivers, record equities, gold’s strongest year since 1979 ...
Ocugen (OCGN) is a clinical-stage biotech focused on modifier gene therapies for inherited retinal diseases, with key ...
Revenue-- $190,000 for the three months ended July 31, 2025, a 34% increase over the same period in 2024, driven by higher portal fees and service revenues exchanged for equity securities. Operating ...
With a 0.06% expense ratio and 2.5% yield, the Vanguard High Dividend Yield ETF is a good choice for investors looking for ...
Investors love to have a look at what stocks billionaires are buying and selling. And the reason is simple. Billionaires ...
Option traders moderately bearish in Alphabet Class A (GOOGL), with shares down $1.37 near $251.16. Options volume relatively light with 144k ...
The global aluminium market has been in structural supply surplus for so long that it's hard to imagine a genuine shortage of ...
You ever walk into a NASCAR race and think, “Man, this place used to be packed to the rafters—what happened?” That’s the ...
Chandan Taparia has recommended three stocks to buy today, 23 September 2025. Taparia recommends buying Muthoot Finance, Samvardhana Motherson International and Canara Bank shares.
Three ambitious bets beyond cars -- robotaxi, robotics, and energy -- could unlock far more value at Tesla than many ...
Zacks Investment Research on MSN
ExxonMobil vs. ConocoPhillips: A Safe Stock or a Risky Upside Play?
ExxonMobil Corporation XOM and ConocoPhillips COP are two energy giants. While XOM has an integrated business model, COP is ...
Markets are shaking off initial hesitation prompted by Powell's warning that there's no 'risk-free path' for policy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results